TWO SIGMA INVESTMENTS, LP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 84 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$639,211
-18.2%
193,115
-19.2%
0.00%
-50.0%
Q1 2024$781,412
+10.5%
238,964
+18.6%
0.00%0.0%
Q4 2023$707,409
-60.4%
201,541
-24.6%
0.00%
-60.0%
Q3 2023$1,785,711
+62.1%
267,322
+103.6%
0.01%
+66.7%
Q2 2023$1,101,607
-49.7%
131,300
-40.5%
0.00%
-50.0%
Q1 2023$2,189,565
-30.2%
220,500
-51.1%
0.01%
-40.0%
Q4 2022$3,136,782
+1.0%
450,687
-22.5%
0.01%
-9.1%
Q3 2022$3,105,000
+28.4%
581,439
-4.1%
0.01%
+37.5%
Q2 2022$2,418,000
+58.7%
606,068
+76.8%
0.01%
+100.0%
Q1 2022$1,524,000
-43.7%
342,887
-49.4%
0.00%
-33.3%
Q4 2021$2,708,000
-61.3%
677,072
-15.0%
0.01%
-62.5%
Q3 2021$6,991,000
-45.4%
796,225
-29.6%
0.02%
-44.8%
Q2 2021$12,811,000
+22.3%
1,130,734
+28.2%
0.03%
+7.4%
Q1 2021$10,478,000
+129.2%
881,962
+32.4%
0.03%
+107.7%
Q4 2020$4,571,000
-7.9%
666,369
-0.5%
0.01%
-27.8%
Q3 2020$4,963,000
+585.5%
669,834
+285.6%
0.02%
+350.0%
Q2 2020$724,000
+273.2%
173,733
+121.1%
0.00%
+100.0%
Q1 2020$194,000
-65.7%
78,560
+91.9%
0.00%0.0%
Q3 2018$565,00040,9290.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,155,300$4,621,0002.77%
Knoll Capital Management, LLC 759,405$3,038,0001.67%
ACUTA CAPITAL PARTNERS, LLC 500,000$2,000,0000.84%
Perceptive Advisors 19,807,758$79,232,0000.61%
Mesirow Financial Investment Management, Inc. 48,711$195,0000.56%
Ghost Tree Capital, LLC 300,000$1,200,0000.43%
Stonepine Capital Management, LLC 200,000$800,0000.37%
APOGEM CAPITAL LLC 86,730$347,0000.23%
JOHNSON & JOHNSON 394,834$1,579,0000.18%
Affinity Asset Advisors, LLC 100,759$403,0000.15%
View complete list of ALDEYRA THERAPEUTICS INC shareholders